Ampres 20 mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

ampres 20 mg/ml solution for injection

sintetica ireland limited - chloroprocaine hydrochloride - solution for injection - 20 milligram(s)/millilitre - esters of aminobenzoic acid; chloroprocaine

Ampres 10mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

ampres 10mg/ml solution for injection

b. braun melsungen ag - chloroprocaine hydrochloride - solution for injection - 10 milligram(s)/millilitre - esters of aminobenzoic acid; chloroprocaine

Ampres 20 mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

ampres 20 mg/ml solution for injection

b. braun melsungen ag - chloroprocaine hydrochloride - solution for injection - 20 milligram(s)/millilitre - esters of aminobenzoic acid; chloroprocaine

Ampres 10mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

ampres 10mg/ml solution for injection

sintetica ireland limited - chloroprocaine hydrochloride - solution for injection - 10 milligram(s)/millilitre - esters of aminobenzoic acid; chloroprocaine

Ampres 10 mg/ml inj. sol. i.thec. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ampres 10 mg/ml inj. sol. i.thec. amp.

nordic group b.v. - chloroprocaine hydrochloride 10 mg/ml - solution for injection - 10 mg/ml - chloroprocaine hydrochloride 10 mg/ml - chloroprocaine

Ampres 20 mg/ml inj. sol. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ampres 20 mg/ml inj. sol. vial

nordic group b.v. - chloroprocaine hydrochloride 20 mg/ml - solution for injection - 20 mg/ml - chloroprocaine hydrochloride 20 mg/ml - chloroprocaine

NESACAINE CE 2% INJ 20MG/ML SOLUTION Canada - English - Health Canada

nesacaine ce 2% inj 20mg/ml solution

astrazeneca canada inc - chloroprocaine hydrochloride - solution - 20mg - chloroprocaine hydrochloride 20mg - local anesthetics

AMPRES Israel - English - Ministry of Health

ampres

cts ltd - chloroprocaine hydrochloride - solution for injection - chloroprocaine hydrochloride 10 mg/ml - chloroprocaine - spinal anaesthesia in adults where the planned surgical procedure should not exceed 40 minutes

NESACAINE- chloroprocaine hydrochloride injection, solution
NESACAINE MPF- chloroprocaine hydrochloride injection, solution United States - English - NLM (National Library of Medicine)

nesacaine- chloroprocaine hydrochloride injection, solution nesacaine mpf- chloroprocaine hydrochloride injection, solution

fresenius kabi usa, llc - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block.  they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

NESACAINE- chloroprocaine hydrochloride injection, solution United States - English - NLM (National Library of Medicine)

nesacaine- chloroprocaine hydrochloride injection, solution

general injectables & vaccines, inc - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block.  they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.